Literature DB >> 19177886

Accounting for the full benefits of childhood vaccination in South Africa.

Till Bärnighausen1, David E Bloom, David Canning, Jennifer O'Brien.   

Abstract

Mesh：

Year:  2008        PMID： 19177886

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  9 in total

1.  A policy framework for accelerating adoption of new vaccines.

Authors:  Orin S Levine; Rana Hajjeh; John Wecker; Thomas Cherian; Katherine L O'Brien; Maria Deloria Knoll; Lois Privor-Dumm; Hans Kvist; Angeline Nanni; Allyson P Bear; Mathuram Santosham
Journal:  Hum Vaccin       Date:  2010-12-01

Review 2.  Public trust and vaccine acceptance--international perspectives.

Authors:  Sachiko Ozawa; Meghan L Stack
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452

Review 3.  Valuing vaccination.

Authors:  Till Bärnighausen; David E Bloom; Elizabeth T Cafiero-Fonseca; Jennifer Carroll O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

4.  Validating child vaccination status in a demographic surveillance system using data from a clinical cohort study: evidence from rural South Africa.

Authors:  James Ndirangu; Ruth Bland; Till Bärnighausen; Marie-Louise Newell
Journal:  BMC Public Health       Date:  2011-05-23       Impact factor: 3.295

5.  A comprehensive framework for considering additional unintended consequences in economic evaluation.

Authors:  Liv Nymark; Anna Vassall
Journal:  Cost Eff Resour Alloc       Date:  2020-08-04

6.  Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study.

Authors:  Ingeborg M van der Putten; Silvia M A A Evers; Rohan Deogaonkar; Mark Jit; Raymond C W Hutubessy
Journal:  BMC Public Health       Date:  2015-04-10       Impact factor: 3.295

Review 7.  The full benefits of adult pneumococcal vaccination: A systematic review.

Authors:  Elizabeth T Cafiero-Fonseca; Andrew Stawasz; Sydney T Johnson; Reiko Sato; David E Bloom
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

8.  Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits.

Authors:  Andrew Stawasz; Liping Huang; Paige Kirby; David Bloom
Journal:  Front Public Health       Date:  2020-07-10

Review 9.  The broader economic impact of vaccination: reviewing and appraising the strength of evidence.

Authors:  Mark Jit; Raymond Hutubessy; May Ee Png; Neisha Sundaram; Jananie Audimulam; Safiyah Salim; Joanne Yoong
Journal:  BMC Med       Date:  2015-09-03       Impact factor: 11.150
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.